These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 15647361

  • 1. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC, Loyet KM, Calemine-Fenaux J, Chauhan V, Wranik B, Ouyang W, Eaton DL.
    Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1116-21. PubMed ID: 15647361
    [Abstract] [Full Text] [Related]

  • 2. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM.
    Nat Immunol; 2005 Jan 25; 6(1):90-8. PubMed ID: 15568026
    [Abstract] [Full Text] [Related]

  • 3. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M, Sedy J, Nelson CA, Murphy KM.
    Adv Immunol; 2006 Jan 25; 92():157-85. PubMed ID: 17145304
    [Abstract] [Full Text] [Related]

  • 4. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.
    Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF.
    Proc Natl Acad Sci U S A; 2005 Sep 13; 102(37):13218-23. PubMed ID: 16131544
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R, Kajikawa M, Shiroishi M, Kuroki K, Maenaka K.
    J Mol Biol; 2011 Nov 04; 413(4):762-72. PubMed ID: 21959263
    [Abstract] [Full Text] [Related]

  • 6. Balancing co-stimulation and inhibition with BTLA and HVEM.
    Murphy KM, Nelson CA, Sedý JR.
    Nat Rev Immunol; 2006 Sep 04; 6(9):671-81. PubMed ID: 16932752
    [Abstract] [Full Text] [Related]

  • 7. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G, Freeman GJ.
    Immunol Rev; 2009 May 04; 229(1):244-58. PubMed ID: 19426226
    [Abstract] [Full Text] [Related]

  • 8. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
    Duhen T, Pasero C, Mallet F, Barbarat B, Olive D, Costello RT.
    Eur J Immunol; 2004 Dec 04; 34(12):3534-41. PubMed ID: 15549770
    [Abstract] [Full Text] [Related]

  • 9. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
    Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ.
    Nat Immunol; 2008 Feb 04; 9(2):176-85. PubMed ID: 18193050
    [Abstract] [Full Text] [Related]

  • 10. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
    Chang YH, Hsieh SL, Chao Y, Chou YC, Lin WW.
    J Biomed Sci; 2005 Feb 04; 12(2):363-75. PubMed ID: 15917993
    [Abstract] [Full Text] [Related]

  • 11. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA.
    Croft M.
    Trends Immunol; 2005 Jun 04; 26(6):292-4. PubMed ID: 15922943
    [Abstract] [Full Text] [Related]

  • 12. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
    Murphy TL, Murphy KM.
    Annu Rev Immunol; 2010 Jun 04; 28():389-411. PubMed ID: 20307212
    [Abstract] [Full Text] [Related]

  • 13. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M, Schulz A, Rossol M, Kendzia E, Kyburz D, Haentzschel H, Baerwald C, Wagner U.
    J Immunol; 2009 Mar 01; 182(5):3139-45. PubMed ID: 19234211
    [Abstract] [Full Text] [Related]

  • 14. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
    Wang XF, Chen YJ, Wang Q, Ge Y, Dai Q, Yang KF, Fang-Xie, Zhou YH, Hu YM, Mao YX, Zhang XG.
    Tissue Antigens; 2007 Feb 01; 69(2):145-53. PubMed ID: 17257317
    [Abstract] [Full Text] [Related]

  • 15. BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.
    Zeng C, Wu T, Zhen Y, Xia XP, Zhao Y.
    Cell Mol Immunol; 2005 Dec 01; 2(6):427-32. PubMed ID: 16426492
    [Abstract] [Full Text] [Related]

  • 16. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
    Cheung TC.
    Recent Pat DNA Gene Seq; 2009 Dec 01; 3(3):177-82. PubMed ID: 19702559
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA, Reddy M, Dede K, Brigham-Burke M, Lyn S, Tan KB, Silverman C, Eichman C, DiPrinzio R, Spampanato J, Porter T, Holmes S, Young PR, Truneh A.
    J Immunol; 1998 Aug 15; 161(4):1786-94. PubMed ID: 9712045
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
    Kosuge H, Suzuki J, Kakuta T, Haraguchi G, Koga N, Futamatsu H, Gotoh R, Inobe M, Isobe M, Uede T.
    Arterioscler Thromb Vasc Biol; 2004 Aug 15; 24(8):1409-15. PubMed ID: 15178556
    [Abstract] [Full Text] [Related]

  • 19. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
    Li C, Chen S, Song J, Liu H, Gu W, Ai H, Zhao B, Zhang S.
    Gene; 2013 Sep 10; 526(2):374-84. PubMed ID: 23732292
    [Abstract] [Full Text] [Related]

  • 20. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex.
    Compaan DM, Gonzalez LC, Tom I, Loyet KM, Eaton D, Hymowitz SG.
    J Biol Chem; 2005 Nov 25; 280(47):39553-61. PubMed ID: 16169851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.